New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareSermorelin vs Eloralintide

Sermorelin vs Eloralintide

Side-by-side comparison of key properties, dosing, and research.

Growth Hormone PeptidesAnti-Aging & Longevity
Sermorelin
GLP-1 / Weight Loss Agonists
Eloralintide
Summary
Sermorelin is a bioidentical synthetic peptide comprising the first 29 amino acids of naturally occurring GHRH. It is FDA-approved for diagnostic use and widely prescribed off-label for anti-aging, stimulating growth hormone production in a natural pulsatile pattern that mimics the body's own rhythm.
Eloralintide is a long-acting amylin analog under development by OPKO Health. Amylin is co-secreted with insulin and regulates post-meal glucose by slowing gastric emptying, suppressing glucagon, and promoting satiety. Eloralintide is designed for once-weekly dosing, differentiating it from the short-acting pramlintide (Symlin). It is being studied for obesity and type 2 diabetes as a complement to GLP-1 based therapies.
Half-Life
10–20 minutes
~7 days (estimated, long-acting design)
Admin Route
SubQ
SubQ
Research
Typical Dose
200–500 mcg
Under investigation in Phase 1/2 trials
Frequency
5–7 days per week
Once weekly
Key Benefits
  • Increases energy and vitality
  • Improves body composition (more muscle, less fat)
  • Enhances skin thickness and elasticity
  • Strengthens immune system
  • Improves sleep quality and REM sleep
  • Supports bone density
  • Enhances mental clarity and focus
  • Safer than exogenous HGH — respects natural feedback loops
  • FDA-approved for GH diagnostic use
  • Once-weekly dosing (vs multiple daily injections for pramlintide)
  • Appetite suppression via central amylin receptor activation
  • Reduction in post-meal glucagon secretion
  • Complementary mechanism to GLP-1 agonists for combination therapy
  • Slows gastric emptying for prolonged satiety
  • Potential additive weight loss when combined with GLP-1 agents
Side Effects
  • Injection site irritation
  • Flushing
  • Headache
  • Dizziness
  • +2 more
  • Nausea
  • Vomiting
  • Decreased appetite
  • Injection site reactions
  • +1 more
Stacks With